Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt reflects on a year marked by promising clinical trial results and a landmark partnership with Merck. He highlights progress in developing treatments for autoimmune diseases and anticipates milestones for the year ahead.
Copyright 2024 – Finance News Network
Source: Finance News Network
12 Nov 2021 - Novatti Group Limited (ASX:NOV) CEO Peter Cook talks about the company's acquiring business and recent licences with Visa and Mastercard.
Read More10 Mar 2025 - Addressing Chronic Conditions with Targeted Treatments
Read More09 Dec 2020 - Alterity Therapeutics Limited (ASX:ATH) Chairman and CEO Geoffrey Kempler provides an update on the company's lead compound ATH434 for Multiple System Atrophy, its dual strategy in Europe and the US and its Phase 2 plans.
Read More27 May 2024 - Jonathan Belz, founder of BFA Global connects Australian and Asian family offices with top global investment opportunities in venture capital, private equity, and technology. He shares insights into the future of alternative assets and investment strategies.
Read More16 May 2024 - Glenn Corrie, CEO of Hazer Group, speaks about their groundbreaking low-emission hydrogen and graphite production technology, recent achievements, and future plans for commercialization and global expansion.
Read More07 Oct 2022 - Stealth Global Holdings Limited (ASX:SGI) Group Managing Director Michael Arnold discusses the business offering, M&A activity, clients, 2025 strategy and financial targets.
Read More25 Jul 2024 - Stuart Crow - Non Executive Chairman - Lake Resources N.L. (ASX:LKE, OTC: LLKKF) is a responsible lithium developer utilising state of-the-art ion exchange extraction technology for production of sustainable, high purity lithium from its flagship Kachi Project in Catamarca Province within the Lithium Triangle in Argentina. Lake also has three additional early-stage projects in this region.
Read More23 Sep 2020 - Shaw and Partners Chief Investment Officer Martin Crabb discusses signs of market recovery, government support, coronavirus vaccines and small cap performance.
Read More16 Dec 2019 - Sienna Cancer Diagnostics Limited (ASX:SDX) Managing Director and CEO Carl Stubbings talks about the company's capital raising and co-development of tests using its SIEN-NET liquid biopsies platform technology.
Read More12 Mar 2025 - The launch of Sofdra and what's next for Botanix
Read More
